Filing Details
- Accession Number:
- 0001493152-20-013088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-10 16:03:48
- Reporting Period:
- 2020-07-10
- Accepted Time:
- 2020-07-10 16:03:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142790 | Tauriga Sciences Inc. | TAUG | Medicinal Chemicals & Botanical Products (2833) | 651102237 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1428173 | M Seth Shaw | C/O Tauriga Sciences, Inc. 555 Madison Avenue New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.00001 | Acquisiton | 2020-07-10 | 700,000 | $0.00 | 4,385,201 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased these shares for an aggregate purchase price of $35,000, at $0.05 per share. All such shares shall be "restricted securities" as such term is defined by the Securities Act of 1933, as amended. The aggregate number of beneficial shares of the Reporting Person also includes 66,667 options with a strike price of $7.50, which have not been exercised through the date of this report.